Skip to main content

Advertisement

Log in

Myasthenia gravis: a changing pattern of incidence

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The annual incidence of myasthenia gravis (MG) ranges from 3 to 30 per 1,000,000 people. Since the mid-1980s, an increasing incidence has been reported, mainly due to late-onset MG. Whether the increase was due to population aging, improved diagnosis and case collection, or a true excess of incidence cases is still under debate. We used a complete enumeration approach by reviewing all possible sources of case collection in the province of Ferrara, Italy, to estimate the MG incidence and its temporal trend over the study period (1985–2007). The mean annual age-adjusted incidence of MG was 18 per 1,000,000, without any significant temporal trend. The incidence rates in the period 1985–1990 were 14 both for early and late-onset MG. Thereafter, a significant increase in incidence of late-onset MG (p < 0.05), and a decrease in early onset MG were detected (p < 0.01). These findings were related to nonthymoma MG. The median age at onset of the disease steadily increased over time. A changing pattern of MG incidence with an increase in frequency of late-onset and a decrease of early onset MG was found in the last years, giving a significant shift to older age at onset of the disease. Unknown environmental factors may have driven this change in MG epidemiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. McGrogan A, Sneddon S, de Vries CS (2010) The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 34:171–183

    Article  PubMed  Google Scholar 

  2. Phillips LH 2nd, Tomer JC, Anderson MS, Cox GM (1992) The epidemiology of myasthenia gravis in central and western Virginia. Neurology 42:1888–1893

    PubMed  Google Scholar 

  3. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I (2003) Myasthenia gravis. A higher-than-expected incidence in the elderly. Neurology 60:1024–1026

    Article  CAS  PubMed  Google Scholar 

  4. Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 65:928–930

    Article  CAS  PubMed  Google Scholar 

  5. Matsui N, Nakane S, Nakagawa Y, Kondo K, Mitsui T, Matsumoto T, Arisaswa K, Kaji R (2009) Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry 80:1168–1171

    Article  CAS  PubMed  Google Scholar 

  6. Aarli JA (2008) Myasthenia gravis in the elderly. Is it different? Ann N Y Acad Sci 1132:238–243

    Article  PubMed  Google Scholar 

  7. Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM, the UK myasthenia gravis survey (2003) Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 74:1105–1108

    Article  CAS  PubMed  Google Scholar 

  8. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia Gravis (2000) Recommendation for clinical research standards. Neurology 55:16–23

    Google Scholar 

  9. Somnier FE, Keiding N, Paulson OB (1991) Epidemiology of Myasthenia Gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol 48:733–739

    CAS  PubMed  Google Scholar 

  10. Aarli JA (1999) Late-onset myasthenia gravis: a changing scene. Arch Neurol 56:25–27

    Article  CAS  PubMed  Google Scholar 

  11. Robertson NP, Deans J, Compston DAS (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire England. J Neurol Neurosurg Psychiatry 65:492–496

    Article  CAS  PubMed  Google Scholar 

  12. Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M, Tsantili P, Papapetropoulos T, Tzartos SJ (2001) Epidemiology of myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 71:352–356

    Article  CAS  PubMed  Google Scholar 

  13. Heldal AT, Owe JF, Gilhus NE, Romi F (2009) Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology 73:150–151

    Article  PubMed  Google Scholar 

  14. Emilia-Romagna Study Group on Clinical, Epidemiological Problems in Neurology (1998) Incidence of myasthenia gravis in the Emilia-Romagna region: a prospective multicenter study. Neurology 51:255–258

    Google Scholar 

  15. Casetta I, Fallica E, Govoni V, Azzini C, Tola M, Granieri E (2004) Incidence of myasthenia gravis in the province of Ferrara. A community-based study. Neuroepidemiology 23:281–284

    Article  CAS  Google Scholar 

  16. Compston DA, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579–601

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the Italian Ministry of University and from Fondazione Cassa di Risparmio di Ferrara.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Casetta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Casetta, I., Groppo, E., De Gennaro, R. et al. Myasthenia gravis: a changing pattern of incidence. J Neurol 257, 2015–2019 (2010). https://doi.org/10.1007/s00415-010-5651-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5651-z

Keywords

Navigation